NCT03340506 2026-04-01
Dabrafenib and/or Trametinib Rollover Study
Novartis
Phase 4 Recruiting
Novartis
University of Oklahoma
Maastricht University Medical Center
Hull University Teaching Hospitals NHS Trust
Zealand University Hospital
Erasmus Medical Center